1. Acknowledgment

   Acknowledgment 20 September 2012 Pages: 361 - 362

2. Effect of Olmesartan Medoxomil on Atherosclerosis

   • Shinji Takai
   • Mizuo Miyazaki

   Current Opinion 20 September 2012 Pages: 363 - 366

3. Intensive Reduction of Low-Density Lipoprotein-Cholesterol

   • Daniel G. Hackam

   Leading Article 20 September 2012 Pages: 367 - 371

   

4. Role of the Renin-Angiotensin-Aldosterone System in Diastolic Heart Failure

   • Juan Bernal
   • Sridevi R. Pitta
   • Deepak Thatai

   Review Article 20 September 2012 Pages: 373 - 381

   

5. The A-SACT (Achievement in Singapore of Cholesterol Targets) Study in Patients with Coronary Heart Disease

   • Kheng-Thye Ho
   • Khong-Whee Chin
   • Don Yin

   Original Research Article 20 September 2012 Pages: 383 - 391

   

6. Bedtime Administration of Graded-Release Diltiazem in Patients with Inadequate BP Control

   • David H. Fitchett
   • Amparo Casanova
   • Anatoly Langer

   Original Research Article 20 September 2012 Pages: 393 - 400

   

7. The Impact of Baseline HR and BP on the Tolerability of Carvedilol in the Elderly

   • Peter S. Macdonald
   • Julie Hill
   • Henry Krum

   Original Research Article 20 September 2012 Pages: 401 - 405

   

8. Clopidogrel Bisulfate

   • Jennifer S. Dickie
   • Lesley J. Scott

   Adis Drug Profile 20 September 2012 Pages: 407 - 414

   

9. Clopidogrel Bisulfate In ST-Segment Elevation Myocardial Infarction

   • Deepak L. Bhatt

   Guest Commentaries 20 September 2012 Pages: 415 - 415

10. Clopidogrel Bisulfate In ST-Segment Elevation Myocardial Infarction

    • Steven R. Steinhubl

    Guest Commentaries 20 September 2012 Pages: 415 - 415

11. Clopidogrel Bisulfate In ST-Segment Elevation Myocardial Infarction

    • Jeffrey W. Moses

    Guest Commentaries 20 September 2012 Pages: 415 - 416

12. Ramipril

    • Vanessa R. Anderson
    • Caroline M. Perry
    • Dean M. Robinson

    Adis Drug Evaluation 20 September 2012 Pages: 417 - 432